Clinical Trials Logo

Peripheral Arterial Disease clinical trials

View clinical trials related to Peripheral Arterial Disease.

Filter by:

NCT ID: NCT04188262 Completed - Clinical trials for Peripheral Arterial Disease

Natural Vascular Scaffold (NVS) Therapy for Treatment of Atherosclerotic Lesions (Activate I)

Start date: May 22, 2020
Phase: Phase 1
Study type: Interventional

The NVS Therapy is being studied to evaluate the safety and efficacy to facilitate retention of acute luminal gain, leading to acute hemodynamic improvement in superficial femoral and popliteal arteries with reference vessel diameters between 4.0 and 7.0 mm and lesion lengths less than or equal to 56mm.

NCT ID: NCT04163471 Completed - Clinical trials for Coronary Artery Disease

VasoStat vs. TR Band for Radial Hemostasis

Start date: June 4, 2018
Phase:
Study type: Observational

VasoStat vs. TR Band compression for Radial Artery Hemostasis Following Transradial Catheterization Without Prior Radial Artery Access

NCT ID: NCT04162418 Completed - Clinical trials for Peripheral Arterial Disease

A Study of the TEmporary Spur StEnt System for the Treatment of Lesions Located in the InfraPoplitEal ARteries Using a LIMUS-base DCB

DEEPER LIMUS
Start date: February 14, 2020
Phase: N/A
Study type: Interventional

This is a non-randomized, prospective, single center pilot study designed to evaluate the safety of the Temporary Spur Stent System to treat patients with infrapopliteal arterial disease, when used in conjunction with a commercially available limus-base drug coated balloon.

NCT ID: NCT04146493 Completed - Clinical trials for Cardiovascular Diseases

Heparin-Binding Protein and Heparins

HepHep
Start date: April 1, 2019
Phase:
Study type: Observational

Heparin-Binding protein is a protein from primary and secretory granluae of white blood cells. It is released when white blood cells become activated and has been advocated as a biomarker for sepsis. The aim of this study is to find out if Heparins in clinical doses can change the level of Heparin-binding protein in plasma.

NCT ID: NCT04110288 Completed - Clinical trials for Peripheral Vascular Disease

VQI DELTA Paclitaxel Device Safety Analysis

VQI-PTX
Start date: January 1, 2017
Phase:
Study type: Observational

The VQI-DELTA Paclitaxel Device Safety Analysis seeks to assess the comparative safety of paclitaxel coated balloons and stents in the treatment of peripheral artery disease (PAD) through analysis of the VQI Peripheral Vascular Intervention (PVI) registry module using the DELTA system.

NCT ID: NCT04107298 Completed - Clinical trials for Peripheral Arterial Disease

Safety and Feasibility of Surmodics SUNDANCEā„¢ Drug Coated Balloon

SWING
Start date: June 29, 2020
Phase: N/A
Study type: Interventional

To evaluate the safety and performance of the Sundanceā„¢ DCB in subjects with occlusive disease of the infrapopliteal arteries.

NCT ID: NCT04070365 Completed - Clinical trials for Peripheral Artery Disease

FLEX Arteriovenous Access Registry

Start date: May 28, 2018
Phase:
Study type: Observational [Patient Registry]

Evaluation of the FLEX Vessel Prep system combined with angioplasty in the treatment of arteriovenous access stenosis.

NCT ID: NCT04062734 Completed - Clinical trials for Peripheral Artery Disease

Endovascular Treatment of Aorto-iliac Disease Using in Situ Fenestration

PREFISIT
Start date: November 27, 2020
Phase:
Study type: Observational

In situ fenestration (ISF) could represent an alternative in the treatment of aorto-iliac disease when usual techniques are not available. The aim of this study was to present the results of ISF in aorto-iliac disease. Data will retrospectively be analyzed. Inclusion criteria will be: a surgical abdominal aortic aneurysm (AAA) with an unsuitable anatomy for a standard endograft, aorto-iliac occlusion with narrow distal aorta (<14mm). Technically, after placement of the endograft, a transjugular intrahepatic access set was used to perform ISF. The hole was secondary enlarged using a cutting or non-compliant balloon. Finally, a kissing stent was performed to the aorto- uni-iliac into a bifurcated endograft.

NCT ID: NCT04060797 Completed - PAD Clinical Trials

Endovascular Denervation Improves Limb Ischemia in Patients With Peripheral Artery Disease

Start date: August 23, 2019
Phase: N/A
Study type: Interventional

Sympathetic overactivity partly promotes the development of peripheral artery disease which mainly leads to ischemia of the lower limbs. Endovascular arterial denervation (ED) is a minimally invasive technique which could deliver Radiofrequency energy by a multi-electrode catheter to the Lower limb artery to restore Sympathetic activity. The purpose of this study is to evaluate the effects of multi-electrode radiofrequency ablation system on lower limb ischemia with PAD.

NCT ID: NCT04058626 Completed - Clinical trials for Peripheral Arterial Disease

TEsting for Arterial Disease in Diabetes (TrEAD) Study

Start date: March 4, 2019
Phase:
Study type: Observational

This study will focus on determining; - How accurate the test is in detecting poor circulation - How it's accuracy compares to other commonly used tests, and - Whether test results are linked to the chance of ulcer healing or amputation. Across 2 hospitals, 305 diabetic patients will be scanned using the focused ultrasound test as well as other commonly used tests to detect poor circulation. Their results will be compared to a full version of the ultrasound test to identify the most accurate.